home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> biomedical companies   |   search    |   registration     |   modification  
 

registry of biomedical companies

 
  June 18, 2018
promoting the transfer of scientific know-how between industry and academia
 
 
Registry of biomedical companies:

[1] [3] [4] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 556 active entries

The Liposome Company, Inc.

One Research Way
Princeton, NJ 08540, USA

Phone: 609-452-7060
Fax: 609-452-1890

Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.

Description:

The Liposome Company, Inc. (Nasdaq: LIPO) develops, manufactures and markets liposome- and lipid-based pharmaceuticals for the treatment of cancer and other life-threatening diseases. ABELCET(R) has been approved for sale in the U.S. and 19 other countries for the treatment of severe, systemic fungal infections. The Company has a pipeline of oncology products including EVACET(TM), in Phase III testing for the treatment of metastatic breast cancer. TLC ELL-12 and other oncology products are in earlier stages of development.

Last update of this entry: before October 1999.

   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by companies 4.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2018 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.